Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

DECONSTRUCT Deconstruction of complex crosslinking damage

Coordinator
Ludwig-Maximilians-Universitaet Muenchen, Germany
Runs
1 May 2024 to 30 April 2029
Status
Running
EU funding
€2.0m
Total cost
€2.0m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101124695

What the project is doing

In the project's own words, from its summary on CORDIS.

Cells are constantly challenged by complex crosslinking damage, which is caused not only by endogenous metabolites, such as reactive aldehydes, but also by various exogenous sources. While crosslinking damage to DNA has been studied extensively, almost all reactive agents act pleiotropically and also damage RNA and proteins. However, due to the complexity of the damage, it is difficult to determine which components of the damage are responsible for specific cellular outcomes.

Therefore, it is unknown how crosslinking damage to RNA and proteins affects cellular homeostasis and how it is detected and resolved. Here, I propose to exploit novel experimental model systems that deconstruct complex crosslinking damage into distinct toxic components. I will combine metabolic labelling with photoactivatable-crosslinking approaches to mimic aldehyde-induced RNA or protein damage in the absence of DNA damage.

We will combine these model systems with genetic and proteomic approaches to define the molecular mechanisms that detect and resolve RNA-protein crosslinks and protein-protein crosslinks. To this end, we will capitalize on preliminary work indicating the existence of an entirely uncharacterized translation-coupled quality control mechanism that ubiquitylates and degrades proteins crosslinked to mRNA. Ultimately, I will build on these mechanistic insights to explore the physiological role of RNA and protein damage in (1) the response to endogenous formaldehyde generated during cellular differentiation and (2) the mechanisms-of-action of chemotherapeutic crosslinkers.

My work will provide a comprehensive view on how complex crosslinking damage affects cellular homeostasis and will challenge the current paradigm that DNA damage is solely responsible for the cytotoxicity of crosslinking agents. As such, my work will address a major blind spot in the fields of cellular quality control and genome stability with wide-ranging implications for cancer therapy and ageing.

Topics

Who is involved

OrganisationCityCountryRole
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI